COMMUNIQUÉS West-GlobeNewswire

Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Efficacy Cohort of LIBERATE Phase 1/2 Trial in Liver Transplant Patients
04/06/2024
Progress in the LIBERATE trial was presented at the American Transplant Congress today London, UK– June 4, 2024 – Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies [...]
Crossject announces highly successful closing of its €8 million rights offering
04/06/2024
Gross fundraising of approximately €8 million or 100% of the planned rights offering as proposed and announced on 30 April 2024 Allows to continue the clinical and regulatory development of ZEPIZURE® until the next [...]
Crossject annonce le vif succès de son augmentation de capital de 8 millions d’euros
04/06/2024
Une levée de fonds d’un montant brut de près de 8 millions d’euros Permet de poursuivre les activités de développement clinique et règlementaire de ZEPIZURE® jusqu’aux prochaines étapes de création de valeur, en [...]
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
04/06/2024
Encouraging clinical activity with observed deepening of responses in 35 evaluable first line head and neck patients treated with HB-200 plus pembrolizumab In a subset of 17 evaluable patients with PD-L1 combined [...]
Oxurion Announces Extraordinary General Shareholders’ Meeting
04/06/2024
Oxurion Announces Extraordinary General Shareholders’ Meeting Leuven, BELGIUM – June 4, 2024 – 07:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces an [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
04/06/2024
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 4 juin 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général [...]
VALNEVA - Declaration of shares and voting rights: May 31, 2024
04/06/2024
VALNEVA Declaration of shares and voting rights May 31, 2024 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 [...]
VALNEVA - Déclaration d’actions et de droits de vote : 31 mai 2024
04/06/2024
VALNEVA Déclaration d’actions et de droits de vote 31 mai 2024 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 rue [...]
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
04/06/2024
Saint-Herblain (France), June 4, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that management will participate at several upcoming investor conferences in the [...]
Valneva annonce sa participation à différentes conférences investisseurs du mois de juin
04/06/2024
Saint-Herblain (France), le 4 juin 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, annonce aujourd’hui que des membres de son équipe dirigeante participeront à différentes [...]
Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, new President of the EAACI
04/06/2024
EAACI focuses on planetary health as a key feature of the research agenda VALENCIA, Spain, June 04, 2024 (GLOBE NEWSWIRE) -- The Closing Ceremony of the EAACI Congress 2024, a meeting forum for experts in Allergy and [...]
Intercept Presents New Sub-Analyses of Phase 3 POISE Data Showcasing the Effect of OCA on Key Liver Biomarkers in Patients with PBC at EASL Congress 2024
04/06/2024
OCA significantly reduces ALT and AST, liver biomarkers associated with poor clinical outcomes, as early as Week 2 in both OCA treatment groups, and by Month 6, normalized ALT in >50% and AST in almost 33% of [...]
Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange
04/06/2024
BEDMINSTER, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical, Inc. is proud to announce that it has been selected to exhibit its groundbreaking AI-driven software, Retrieve Dx, at the prestigious Vizient [...]
Dr. John Q. Cook of the Whole Beauty® Institute Chicago to Present at the International Society of Aesthetic Plastic Surgery World Congress
04/06/2024
Board-Certified Plastic Surgeon Dr. John Q. Cook Will Present at the 28th World Congress on Aesthetic Plastic Surgery in Cartagena, Colombia CHICAGO, June 04, 2024 (GLOBE NEWSWIRE) -- Dr. John Q. Cook of the Whole [...]
Physicians’ Right to Free Speech Upheld in AAPS v. ABIM
04/06/2024
TUSCON, Ariz., June 04, 2024 (GLOBE NEWSWIRE) -- A precedent-setting ruling in favor of the First Amendment was issued today by the U.S. Court of Appeals for the Fifth Circuit. This influential Court established the [...]
Nordic Naturals Joins 40th Annual California Coastal Cleanup to Protect the Health of the Oceans
04/06/2024
WATSONVILLE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- With its dedication to sustainable practices, Nordic Naturals is proud to announce its participation in the 40th Annual California Coastal Cleanup on Sept. 21, led [...]
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
04/06/2024
PITTSBURGH, June 04, 2024 (GLOBE NEWSWIRE) -- BlueSphere Bio , a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with [...]
18 Genesis HealthCare Affiliated Centers Earn 2024 AHCA/NCAL Bronze National Quality Award
04/06/2024
National award signifies a formal commitment to continuous improvement in quality care. KENNETT SQUARE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Genesis HealthCare, Inc., one of the largest post-acute providers in the [...]
TytoCare Introduces Major Release to Increase Flexibility and Accessibility of Care Delivery
04/06/2024
Update for TytoCare’s Home Smart Clinic Adds Features to Facilitate Ease-of-Use and Seamless Integration, Ultimately Expanding Care to Thousands More Users NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- TytoCare , a [...]

Pages